Study to Assess Demographic, Pharmacologic, Biomarker, Clinical Features and Quality of Life (QoL) of Participants With Lupus Nephritis
Conditions
- Systemic Lupus Erythematosus
Interventions
- OTHER: Participant completed survey
- OTHER: Medical chart review
Sponsor
GlaxoSmithKline